Cullinan Therapeutics, Inc. (CGEM)
22.06
-0.10
(-0.45%)
USD |
NASDAQ |
Sep 04, 16:00
22.06
0.00 (0.00%)
After-Hours: 19:32
Cullinan Therapeutics Cash and Short Term Investments (Annual) : 377.90M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 377.90M |
| December 31, 2024 | 398.98M |
| December 31, 2023 | 467.07M |
| December 31, 2022 | 467.29M |
| Date | Value |
|---|---|
| December 31, 2021 | 290.47M |
| December 31, 2020 | 210.21M |
| December 31, 2019 | 98.63M |
| December 31, 2018 | 33.83M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Rallybio Corp. | 54.74M |
| MapLight Therapeutics, Inc. | 305.10M |
| Arrowhead Pharmaceuticals, Inc. | 919.37M |
| Oncolytics Biotech, Inc. | 5.202M |
| Sangamo Therapeutics, Inc. | 20.95M |